Dapagliflozin in Patients with Chronic Kidney Disease
Authors
Hiddo Heerspink•Bergur Stefánsson•David Wheeler
Journal
New England Journal of Medicine
Published
September 24, 2020
Abstract
Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, with or without type 2 diabetes, is not known.